Tongxinluo capsule is a traditional Chinese medicine compound preparation composed of 12 components, which is widely used in the treatment of cardiovascular and cerebrovascular diseases in China. Although it seems to be mainly used for the treatment of cardiovascular diseases from the name, it is actually widely used in the treatment of cerebral infarction with definite curative effect.
Studies have found that Tongxinluo can reduce neuronal death after cerebral infarction, reduce scar hyperplasia caused by cerebral infarction, improve nerve function, promote neuronal regeneration and angiogenesis after cerebral infarction, etc. In addition, Tongxinluo can also remove pathological tissue debris and metabolic waste after cerebral infarction, provide a suitable microenvironment for nerve regeneration and vascular proliferation, and improve the life treatment of stroke patients. It can improve the outcome of stroke and has a good brain protection effect
Tongxinluo ingredients are unique. Among them, ginseng can replenish qi and nourish yin and improve human immunity; leeches can activate blood circulation and remove blood stasis, improving blood circulation; scorpions and centipeding have the effect of detoxification and detumescence, dredging collaterals and relieving pain, and can relieve the symptoms of angina pectoris and myocardial ischemia. These components of traditional Chinese medicine cooperate with each other to form the unique efficacy of Tongxinluo capsule.
Tongxinluo capsule can inhibit platelet aggregation, which is the same as aspirin and clopidogrel. Tongxinluo can also effectively reduce the level of hyperlipidemia in patients with acute cerebral infarction, increase the level of high-density lipoprotein, improve the patients' blood hyperviscosity, repair the damaged vascular endothelium, which is related to the action of enzymes and hirudin in the five kinds of worm drug active components of Tongxinluo. With the extension of medication time, it can reduce the carotid intima-media thickness and reduce the plaque volume. These effects are similar to those of statins, and by stabilizing the plaque in the patient's blood vessels, the plaque rupture is prevented from triggering cerebral infarction again. A multicenter study of Tongxinluo in the treatment of acute and subacute ischemic stroke in 11 hospitals found that the recovery of patients treated with Tongxinluo was better than that of the control group after 28 days, and the recurrence rate of patients treated with Tongxinluo was lower than that of the control group after 1 year of follow-up.
Tongxinluo capsule can not only improve the neurological deficit of patients with acute cerebral infarction, but also reduce the recurrence rate of cerebral infarction. A multi-hospital study led by West China Hospital of Sichuan University showed that Tongxinluo can improve the neurological deficit of patients with cerebral infarction, improve the quality of daily life, and reduce the recurrence rate of 1 year by 33%. Tongxinluo can also improve memory impairment, enhance memory, improve intelligence and quality of life in patients with vascular dementia, and reduce transient ischemic attacks.
Tongxinluo capsule is 2-4 capsules once, 3 times a day, in order to avoid gastrointestinal reactions, can be taken after meals, generally 4 weeks for a course of treatment, according to the condition can be extended medication time, recommended clinical application course is not more than 6 months, need long-term use, should be used under the guidance of a doctor, in addition, hemorrhagic diseases, pregnant women and women's menstrual period and Yin deficiency and fire hyperactivity type stroke are forbidden.
